These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8356539)

  • 1. [Review of a technic for the estimation of area under the concentration curve in pharmacokinetic analysis].
    Bourget P; Delouis JM
    Therapie; 1993; 48(1):1-5. PubMed ID: 8356539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of the theory of the optimal sampling scheme for bioequivalence studies].
    Tod M; Petitjean O; Nicolas P
    Therapie; 1993; 48(1):7-13. PubMed ID: 8356559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.
    Hulin A; Blanchet B; Audard V; Barau C; Furlan V; Durrbach A; Taïeb F; Lang P; Grimbert P; Tod M
    Ther Drug Monit; 2009 Apr; 31(2):224-32. PubMed ID: 19214145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.
    Ragette R; Kamler M; Weinreich G; Teschler H; Jakob H
    J Heart Lung Transplant; 2005 Sep; 24(9):1315-9. PubMed ID: 16143250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic parameters estimation using adaptive Bayesian P-splines models.
    Jullion A; Lambert P; Beck B; Vandenhende F
    Pharm Stat; 2009; 8(2):98-112. PubMed ID: 18481279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Graphic method of assessing the maximum cumulative excretion of a drug].
    Firsov AA
    Antibiotiki; 1983 Dec; 28(12):904-8. PubMed ID: 6660844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating integrals using quadrature methods with an application in pharmacokinetics.
    Bailer AJ; Piegorsch WW
    Biometrics; 1990 Dec; 46(4):1201-11. PubMed ID: 2085635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.
    Chiou WL
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):539-46. PubMed ID: 731416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors.
    Warren K; Gervais A; Aikin A; Egorin M; Balis FM
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):206-12. PubMed ID: 15156345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.
    Gagnon RC; Peterson JJ
    J Pharmacokinet Biopharm; 1998 Feb; 26(1):87-102. PubMed ID: 9773394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-compartmental analysis.
    Gabrielsson J; Weiner D
    Methods Mol Biol; 2012; 929():377-89. PubMed ID: 23007438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.
    Mahmood I; Miller R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):439-45. PubMed ID: 10507242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising time samples for determining area under the curve of pharmacokinetic data using non-compartmental analysis.
    Hughes JH; Upton RN; Reuter SE; Phelps MA; Foster DJR
    J Pharm Pharmacol; 2019 Nov; 71(11):1635-1644. PubMed ID: 31412422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-compartmental analysis of pharmacokinetic data after multiple intravenous and oral administration.
    Rohatagi S; Kan S; Derendorf H
    Pharmazie; 1997 Jul; 52(7):529-32. PubMed ID: 9266589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raman spectroscopic method for the determination of medroxyprogesterone acetate in a pharmaceutical suspension: validation of quantifying abilities, uncertainty assessment and comparison with the high performance liquid chromatography reference method.
    De Beer TR; Baeyens WR; Vermeire A; Broes D; Remon JP; Vervaet C
    Anal Chim Acta; 2007 Apr; 589(2):192-9. PubMed ID: 17418181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.